Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Pulmonx Corporation (LUNG)

3.0050 -0.1600 (-5.06%)
At close: October 30 at 4:00:00 PM EDT
2.9800 -0.0250 (-0.83%)
After hours: October 30 at 7:48:49 PM EDT
Trade Pulmonx on Coinbase
Chart Range Bar
Loading chart for LUNG
  • Previous Close 3.1650
  • Open 3.0650
  • Bid 2.8500 x 200
  • Ask 2.9200 x 300
  • Day's Range 2.7900 - 3.2300
  • 52 Week Range 1.1300 - 3.2500
  • Volume 2,397,648
  • Avg. Volume 630,170
  • Market Cap (intraday) 126.923M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0100
  • Earnings Date Oct 27, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 3.70
  • Zacks Rating Bullish

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

www.pulmonx.com

296

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LUNG
35.97%
S&P 500 (^GSPC)
10.73%

1-Year Return

LUNG
70.74%
S&P 500 (^GSPC)
11.11%

3-Year Return

LUNG
61.91%
S&P 500 (^GSPC)
81.91%

5-Year Return

LUNG
92.28%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 22.84M
Earnings -8.39M
Profit Margin -36.76%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-10M
0
10M
20M
-60.0%
-50.0%
-40.0%

Analyst Insights

View More

Analyst Price Targets

2.50 Low
3.70 Average
3.0050 Current
5.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/28/2026
Analyst Stifel
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 2.5 -> 4

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    129.06M

  • Enterprise Value

    132.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    1.43

  • Price/Book (mrq)

    3.77

  • Enterprise Value/Revenue

    1.49

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.93%

  • Return on Assets (ttm)

    -19.82%

  • Return on Equity (ttm)

    -90.31%

  • Revenue (ttm)

    88.78M

  • Net Income Avi to Common (ttm)

    -42.55M

  • Diluted EPS (ttm)

    -1.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    52.69M

  • Total Debt/Equity (mrq)

    164.75%

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

3.0050 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: